Tempus AI, Inc. vs. Guardant Health Inc.
Explore the PTAB proceeding IPR2025-01434 filed by Tempus AI, Inc. on 2025-08-15. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.
Proceeding Overview
Proceeding Number
IPR2025-01434
Filing Date
2025-08-15
Accorded Filing Date
2025-08-15
Institution Decision Date
2025-12-18
Last Modified Date
2026-01-21
Proceeding Type
IPR
Termination Date
2025-12-18
Trial Status
Discretionary Denial
Parties & Counsel
Petitioner
Tempus AI, Inc.
Represented By
Glass, Jameset alPatent Owner / Respondent
Guardant Health Inc.
Represented By
Rosato, Michaelet alPatent Information
Tribunal & APJ Panel Intelligence
Tribunal
Patent Trial and Appeal Board (USPTO)
Technology Center
TC 1600 - Biotechnology & Organic Chemistry
Decisions Rendered
1 Total
Proceeding Status
Discretionary Denial
Administrative Patent Judges (APJ Panel)
Board Decisions & Rulings (1)
Address and Attorney/Agent Information
Power of Attorney & Correspondence
Attorney / Agent Information
| Reg # | Name | Phone |
|---|---|---|
| 34298 | Scott Bortner | +1 650-383-7237 |
| 34448 | Richard Torczon Jr | +1 202-973-8811 |
| 37505 | Joe Liebeschuetz | +1 650-838-2038 |
| 39666 | Um Ping Eng | +1 650-493-9300 |
| 44409 | Karen Wong | +1 650-493-9300 |
| 47664 | Michael Hostetler | +1 858-350-2306 |
| 52182 | Michael Rosato | +1 206-883-2529 |
| 52353 | Lorelei Westin | +1 858-350-2225 |
Global Patent Family Cross-Litigation Radar
CasLoc 360ยฐ Radar 25 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| ๐บ๐ธ United States | US 11,149,306 B2 Asserted | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 11,149,307 B2 | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 11,434,531 B2 | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 11,767,556 B2 | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 11,767,555 B2 | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 11,667,967 B2 | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 11,649,491 B2 | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 11,639,525 B2 | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 11,639,526 B2 | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 11,959,139 B2 | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 12,054,774 B2 | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 12,098,421 B2 | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 12,024,745 B2 | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 12,024,746 B2 | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US 12,098,422 B2 | US Continuation / Sibling | View Official Patent → |
TwinStrand Biosciences, Inc. v. Guardant Health, Inc.